pemgarda
(pemivibart)Invivyd, Inc
Usage: PEMGARDA (pemivibart) is authorized for emergency use as pre-exposure prophylaxis against COVID-19 in adults and adolescents (12 years and older, ≥40 kg) who are not currently infected with SARS-CoV-2 and have moderate-to-severe immune compromise, diminishing their ability to respond adequately to vaccination.